The global leader in healthcare naming!

Including nonproprietary (USAN/INN) names, drug brand names, medical device names, OTC product names, and COVID-19 vaccines, repurposed drugs, and diagnostics! We name over 75% of nonproprietary (USAN/INN) and drug brand name approvals worldwide!

1242
Healthcare Clients
4191
Total Healthcare Names
16
Obesity Names
Animal Health - 27
Antibiotic - 102
Antifungal - 27
Antiviral - 127
Antiviral/HIV - 51
Biologic Suffix - 61
Biosimilar Name - 29
Cardiovascular - 201
Class Name - 9
Clinical Trial Name - 116
Corporate Identity - 122
COVID-19 - 31
Covid-19 - 32
Dermatology - 144
Division Identity - 16
Endocrinology - 184
Gastrointestinal - 113
Hematology - 147
Identity Research - 15
Immunology - 237
Medical Device - 264
Men's Health - 11
Metabolic Disorders - 67
Musculoskeletal - 36
Nephrology - 32
Neurology - 355
Nutritional Agent - 52
Obesity - 16
Oncology - 747
Ophthalmology - 139
Oral Care - 8
OTC - 136
Pain & Inflammation - 166
Product Identity - 7
Program Name - 18
Respiratory - 205
Service Name - 16
Tagline - 11
Technology Name - 34
Urology - 26
USAN/INN - 1396
Vaccine - 104
Website - 19
Women's Health - 139

* Denotes a comprehensive report of the safety regulatory research prepared by B/DSI for submission of this name candidate to FDA, EMA, Health Canada, JMHLW, ANVISA, ROSZDRAVNADZOR, CDSCO, CFDA, KOREA MFDS, and/or other Regulatory Agencies.

CLIENTNAMECATEGORY
ALIZYMECETILISTAT Obesity
CITIUS PHARMASUPRENZA Obesity
EISAIBELVIQ *Obesity
GSKALLI Obesity
JANSSENefinopegdutide Obesity
NOVO NORDISKSAXENDA *Obesity
OREXIGEN THERAPEUTICSCONTRAVE *Obesity
PFIZERREDUX Obesity
RHYTHM PHARMACEUTICALSIMCIVREE *Obesity
RIEMSERALVALIN Obesity
ROCHEXENICAL Obesity
SANOFIACOMPLIA *Obesity
SHIONOGI PHARMAvelneperit Obesity
TAKEDAOBLEAN (オブリーン) Obesity
VIVUSQSYMIA *Obesity
ZAFGENaclimostat Obesity